IRIS Accounts Production v24.1.9.2 12101169 Board of Directors 1.5.23 5.4.24 5.4.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary C 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh121011692023-04-30121011692024-04-05121011692023-05-012024-04-05121011692022-04-30121011692022-05-012023-04-30121011692023-04-3012101169ns15:EnglandWales2023-05-012024-04-0512101169ns14:PoundSterling2023-05-012024-04-0512101169ns10:Director12023-05-012024-04-0512101169ns10:PrivateLimitedCompanyLtd2023-05-012024-04-0512101169ns10:SmallEntities2023-05-012024-04-0512101169ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-0512101169ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-0512101169ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-0512101169ns10:FullAccounts2023-05-012024-04-0512101169ns10:OrdinaryShareClass12023-05-012024-04-0512101169ns10:OrdinaryShareClass22023-05-012024-04-0512101169ns10:OrdinaryShareClass32023-05-012024-04-0512101169ns10:OrdinaryShareClass332023-05-012024-04-0512101169ns5:CurrentFinancialInstruments2024-04-0512101169ns5:CurrentFinancialInstruments2023-04-3012101169ns5:ShareCapital2024-04-0512101169ns5:ShareCapital2023-04-3012101169ns5:RetainedEarningsAccumulatedLosses2024-04-0512101169ns5:RetainedEarningsAccumulatedLosses2023-04-3012101169ns10:RegisteredOffice2023-05-012024-04-0512101169ns5:PlantMachinery2023-05-012024-04-0512101169ns5:FurnitureFittings2023-05-012024-04-0512101169ns5:PlantMachinery2023-04-3012101169ns5:FurnitureFittings2023-04-3012101169ns5:PlantMachinery2024-04-0512101169ns5:FurnitureFittings2024-04-0512101169ns5:PlantMachinery2023-04-3012101169ns5:FurnitureFittings2023-04-3012101169ns5:DeferredTaxation2023-04-3012101169ns5:DeferredTaxation2023-05-012024-04-0512101169ns5:DeferredTaxation2024-04-0512101169ns10:OrdinaryShareClass12024-04-0512101169ns10:OrdinaryShareClass22024-04-0512101169ns10:OrdinaryShareClass32024-04-05121011691ns10:Director12023-04-30121011691ns10:Director12022-04-30121011691ns10:Director12023-05-012024-04-05121011691ns10:Director12022-05-012023-04-30121011691ns10:Director12024-04-05121011691ns10:Director12023-04-30
REGISTERED NUMBER: 12101169 (England and Wales)















Unaudited Financial Statements

for the Period 1 May 2023 to 5 April 2024

for

Medniuk & Medniuk Limited

Medniuk & Medniuk Limited (Registered number: 12101169)






Contents of the Financial Statements
for the Period 1 May 2023 to 5 April 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Medniuk & Medniuk Limited (Registered number: 12101169)

Balance Sheet
5 April 2024

5.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,460 1,391

CURRENT ASSETS
Cash at bank 24,750 3,564

CREDITORS
Amounts falling due within one year 5 13,931 1,717
NET CURRENT ASSETS 10,819 1,847
TOTAL ASSETS LESS CURRENT
LIABILITIES

13,279

3,238

PROVISIONS FOR LIABILITIES 6 467 317
NET ASSETS 12,812 2,921

CAPITAL AND RESERVES
Called up share capital 7 201 200
Retained earnings 12,611 2,721
SHAREHOLDERS' FUNDS 12,812 2,921

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 5 April 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 5 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medniuk & Medniuk Limited (Registered number: 12101169)

Balance Sheet - continued
5 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 September 2024 and were signed on its behalf by:





Dr A M Darweish-Medniuk - Director


Medniuk & Medniuk Limited (Registered number: 12101169)

Notes to the Financial Statements
for the Period 1 May 2023 to 5 April 2024

1. STATUTORY INFORMATION

Medniuk & Medniuk Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12101169

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Medniuk & Medniuk Limited (Registered number: 12101169)

Notes to the Financial Statements - continued
for the Period 1 May 2023 to 5 April 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1 May 2023 1,402 1,498 2,900
Additions - 1,897 1,897
Disposals (1,402 ) (498 ) (1,900 )
At 5 April 2024 - 2,897 2,897
DEPRECIATION
At 1 May 2023 1,052 457 1,509
Charge for period 350 478 828
Eliminated on disposal (1,402 ) (498 ) (1,900 )
At 5 April 2024 - 437 437
NET BOOK VALUE
At 5 April 2024 - 2,460 2,460
At 30 April 2023 350 1,041 1,391

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.24 30.4.23
£    £   
Tax 12,316 796
Directors' current accounts 655 327
Accrued expenses 960 594
13,931 1,717

6. PROVISIONS FOR LIABILITIES
5.4.24 30.4.23
£    £   
Deferred tax 467 317

Deferred
tax
£   
Balance at 1 May 2023 317
Provided during period 150
Balance at 5 April 2024 467

Medniuk & Medniuk Limited (Registered number: 12101169)

Notes to the Financial Statements - continued
for the Period 1 May 2023 to 5 April 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 5.4.24 30.4.23
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
1 Ordinary C £1 1 -
(30.4.23 -
NIL)
201 200

Allotted and issued:
Number: Class: Nominal 5.4.24 30.4.23
value: £    £   
1 Share capital 3 £1 1 -
(30.4.23 -
NIL)

The following shares were issued during the period for cash at par :

1 Ordinary C share of £1

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 5 April 2024 and the year ended 30 April 2023:

5.4.24 30.4.23
£    £   
Dr A M Darweish-Medniuk
Balance outstanding at start of period (327 ) (1,109 )
Amounts advanced 43,694 9,986
Amounts repaid (44,022 ) (9,204 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period (655 ) (327 )

9. ULTIMATE CONTROLLING PARTY

The controlling party is the directors.